
India makes diabetes treatment more accessible: Empagliflozin prices slashed by 90%
IANS The price of empagliflozin, a commonly prescribed diabetes drug, has been slashed by a staggering 90% in India. This significant reduction, made possible by the entry of generic versions, is poised to revolutionize diabetes treatment, making it more …